Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
about
Drugs for the treatment of nausea and vomiting in adults in the emergency department settingDrugs for the treatment of nausea and vomiting in adult patients in the emergency department settingMoxibustion for alleviating side effects of chemotherapy or radiotherapy in cancer patientsTreating nausea and vomiting in palliative care: a reviewA Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and VomitingPrevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid TumorsImpact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.Ramosetron hydrochloride for the prevention of cancer chemotherapy induced nausea and vomiting: The Indian experienceAdverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative studyNetupitant PET imaging and ADME studies in humans.Insight in the prediction of chemotherapy-induced nausea.Pharmacokinetic evaluation of fosaprepitant dimeglumineEfficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.Compliance with National Comprehensive Cancer Network anti-emesis guidelines in a Community Hospital Cancer Center.Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome.The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting.A Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and EmesisPneumocystis carinii pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 cases report and literature review.Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.Assessing prescribing patterns for the prevention of chemotherapy-induced nausea and vomiting in the national center for cancer care and research.Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation.Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinolCurrent pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant.Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model.Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy.Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer.NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK.A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men.Patient-practitioner perception gap in treatment-induced nausea and vomiting.Prevention and management of chemotherapy-induced nausea and vomiting.Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.Emesis control by aprepitant in children and adolescents with chemotherapy.A Study on Utilization and Evaluation of Antiemetics in Chemotherapy-induced Nausea and Vomiting.
P2860
Q24186973-A51E3F22-448B-4B8C-9765-E20ED6220C67Q24201285-ED8BD9F1-900B-4495-8A3E-60289BAEBD5DQ24202551-A6AB9FAD-CFE4-4191-A6CE-6BA1DB01B2D4Q24635649-272B73AE-DDEC-4211-9076-1EE036147719Q26784064-449E6A8F-929C-425E-8291-F9D5B2753F9FQ26784083-1119CC8C-39C6-4A9C-92F2-FB65FA6FADABQ30316569-7525247F-D8A7-432E-86CF-36AFDE5A00CEQ33584510-A0FD8460-20F0-48C9-AC34-97D23BCE2C88Q33913102-09573854-438E-43A5-B60D-EDC7D91DFC66Q34377521-B2D76841-B9F2-4ACB-9655-3AB818A9476FQ34472901-56FA56E9-CF92-4972-B4AD-E504CED3CE09Q35163168-D25560BB-3356-45AF-BA62-E006C3F2DD05Q35195218-3A721EEE-1682-4121-8489-1A1979AE66A3Q35224952-D829B6B8-73A7-43D5-8944-8DAA1D930A2AQ35232897-CBF84160-BAC5-432C-AE1E-2DD1DD60B89FQ35766352-7A458DD3-62DB-400C-AABB-5271ECD0752AQ36015715-CA2D3779-7256-46CD-9C47-8362A1FB5DC8Q36083569-7EC61070-1A26-49DF-9153-D1FDA4D0F397Q36222937-2A319C99-FC3A-408C-A2DC-AB9FF0B16A51Q36806846-2FF8855F-FBFD-4531-9C0D-DA5B7D46A9F9Q37301485-D3B9367F-C366-4846-8C45-130288B89427Q37397648-EE344C3C-1F8E-48FB-A874-DEC3C3EE8426Q37609798-F9C6F676-0BBE-413F-A20F-088A5700CE13Q37636064-8A0A7085-990D-4250-96EA-F4428585BFF4Q37657353-B7CC0B03-D650-4706-ADD7-CA7E95F98AB4Q37661865-9B2163A4-2018-4F34-A690-EA2782762A74Q37673503-CB926B05-B411-4573-B394-623B74B1BB77Q37735410-C6A247CA-A2EE-4DB2-94BD-4512E24C95A2Q38049229-12F5B86B-F823-40F7-AA2C-81E8C9FB241FQ38915622-93F075D8-2E0B-475E-BE66-FF403CD56DC4Q38943088-C6EB9E05-D12F-4DE1-9220-4507BF4E3C9CQ38969688-E803BEB7-5417-48E3-A406-FFB4BD9960C1Q39816020-9BCB803A-9679-44BD-BDAB-8FA8C75C69CCQ40586658-1667992C-129A-46B5-A60C-9B1E5188ED14Q40801409-93D88C18-9801-45DD-968E-77F80E543896Q42642028-A98EB67E-FA86-40E6-ADF8-E38D1713F0AAQ43032859-5BF6B69A-6455-4D52-BF9F-84F489C0A3DEQ44391147-6F38681C-3F2B-4C7E-A42D-82E5B742A416Q45902908-D813C6A9-2BCA-47F8-9B7C-5B4A94F3964DQ47112651-46D5272D-245C-487C-BF56-2F812422552C
P2860
Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Guidelines for antiemetic trea ...... t, and future recommendations.
@ast
Guidelines for antiemetic trea ...... t, and future recommendations.
@en
type
label
Guidelines for antiemetic trea ...... t, and future recommendations.
@ast
Guidelines for antiemetic trea ...... t, and future recommendations.
@en
prefLabel
Guidelines for antiemetic trea ...... t, and future recommendations.
@ast
Guidelines for antiemetic trea ...... t, and future recommendations.
@en
P2093
P1433
P1476
Guidelines for antiemetic trea ...... t, and future recommendations.
@en
P2093
Christoph Sippel
Hans-Joachim Schmoll
Karin Jordan
P304
P356
10.1634/THEONCOLOGIST.12-9-1143
P577
2007-09-01T00:00:00Z